Ticker Details
Korro Bio, Inc.
IPO Date:	October 4, 2019
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$193.49M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.94 | 4.71%
Avg Daily Range (30 D):	$0.42 | 3.43%
Avg Daily Range (90 D):	$0.46 | 3.81%

Institutional Daily Volume
Avg Daily Volume:	.31M
Avg Daily Volume (30 D):	.11M
Avg Daily Volume (90 D):	.12M

Trade Size
Avg Trade Size (Sh.):	127
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	52

Institutional Trades
Total Institutional Trades:	318
Avg Institutional Trade:	$1.89M
Avg Institutional Trade (30 D):	$7.66M
Avg Institutional Trade (90 D):	$3.62M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.51M
Avg Closing Trade (30 D):	$7.66M
Avg Closing Trade (90 D):	$5.02M
Avg Closing Volume:	128.84K

News

Jan 8, 2026 @ 1:00 PM Korro to Present at the 44th Annual J.P. Morgan He... Source: Na

Mar 14, 2025 @ 12:00 PM KRRO-110 Receives Orphan Drug Designation from U.S... Source: N/A

Nov 8, 2024 @ 7:34 AM 4 Biotech Stocks With AI, Machine Learning Prowess... Source: Professor Ari Zoldan

Sep 19, 2024 @ 10:50 AM Novo Nordisk Just Took a $530 Million Step Onto Mo... Source: The Motley Fool

May 20, 2024 @ 6:30 PM Korro Presents Additional Preclinical Data for KRR... Source: Korro Bio, Inc.

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-10	$-1.07	$-1.69
Diluted EPS	$-10	$-1.07	$-1.69
Revenue	$2.38M	$M	$M
Gross Profit
Net Income / Loss	$-106.64M	$-18.92M	$-19.63M
Operating Income / Loss	$-110.18M	$-20.11M	$-20.44M
Cost of Revenue
Net Cash Flow	$-9.7M	$-37.79M	$39.87M
PE Ratio